Works matching IS 2160763X AND DT 2019 AND VI 8 AND IP 3

Results: 17

Pharmacokinetics of Tacrolimus Coadministered With Letermovir in Allogeneic Hematopoietic Stem Cell Transplantation Patients.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 411, doi. 10.1002/cpdd.669

By:

Guo, Yong‐mei;
Abumiya, Maiko;
Yamashita, Takaya;
Ubukawa, Kumi;
Takahashi, Naoto

Publication type:

Article

Designer Benzodiazepines: A Review of Published Data and Public Health Significance.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 266, doi. 10.1002/cpdd.667

By:

Greenblatt, H. Karl;
Greenblatt, David J.

Publication type:

Article

Pharmacokinetics, Food Effect, Ketoconazole Interaction, and Safety of JTK‐853, a Novel Nonnucleoside HCV Polymerase Inhibitor, After Ascending Single and Multiple Doses in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 371, doi. 10.1002/cpdd.656

By:

Tamaki, Sekihiro;
Shibata, Tsutomu;
Hunt, Thomas;
Gerhardt, Barbara;
Yamada, Hiroyuki;
Pai, Sudhakar M.

Publication type:

Article

Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and Safety.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 281, doi. 10.1002/cpdd.650

By:

Lee, Edward;
Gibbs, John P.;
Emery, Maurice G.;
Block, Geoffrey;
Wasserman, Scott M.;
Hamilton, Lisa;
Kasichayanula, Sreeneeranj;
Hanafin, Patrick;
Somaratne, Ransi;
Egbuna, Ogo

Publication type:

Article

A Phase 1 Randomized, Placebo‐Controlled Trial With a Topical Inhibitor of Stearoyl‐Coenzyme A Desaturase 1 Under Occluded and Nonoccluded Conditions.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 270, doi. 10.1002/cpdd.644

By:

Brigandi, Richard A.;
Zhu, John;
Murnane, Amy A.;
Reedy, Beth Ann;
Shakib, Sepehr

Publication type:

Article

A Randomized, Double‐Blind, Single‐Dose, Crossover Study to Demonstrate the Bioequivalence of 2 Formulations of Albiglutide in Healthy Adult Participants.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 361, doi. 10.1002/cpdd.606

By:

Shaddinger, Bonnie C.;
Vlasakakis, Georgios;
Soffer, Joseph;
Thorpe, Karl M.;
Hatch, Daniel;
Nino, Antonio J.

Publication type:

Article

Relative Bioavailability and Food Effect Evaluation for 2 Tablet Formulations of Asciminib in a 2‐Arm, Crossover, Randomized, Open‐Label Study in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 385, doi. 10.1002/cpdd.602

By:

Menssen, Hans D.;
Quinlan, Michelle;
Kemp, Charisse;
Tian, Xianbin

Publication type:

Article

Comparative Bioavailability of Sildenafil 50‐mg Film‐Coated Tablets and 50‐mg Orally Disintegrating Films in Healthy Mexican Subjects: Results From a Randomized, Open‐Label, Crossover Study.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 404, doi. 10.1002/cpdd.599

By:

Aguirre, Luis García;
Olmedo, Isabel Ruiz;
Nolasco, Araceli Medina;
Romo, Yamanqui Ibáñez;
Reyes, Liz Medina;
Hernández, Dolores Adriana Aguilera;
Vargas, Ana Laura Rojas

Publication type:

Article

Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Alicapistat, a Selective Inhibitor of Human Calpains 1 and 2 for the Treatment of Alzheimer Disease: An Overview of Phase 1 Studies.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 290, doi. 10.1002/cpdd.598

By:

Lon, Hoi‐Kei;
Mendonca, Nuno;
Goss, Sandra;
Othman, Ahmed A.;
Locke, Charles;
Jin, Ziyi;
Rendenbach‐Mueller, Beatrice

Publication type:

Article

Evaluation of Food and Spherical Carbon Adsorbent Effects on the Pharmacokinetics of Roxadustat in Healthy Nonelderly Adult Male Japanese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 304, doi. 10.1002/cpdd.597

By:

Shibata, Tomohisa;
Nomura, Yuki;
Takada, Akitsugu;
Ueno, Mai;
Katashima, Masataka;
Yazawa, Rie;
Furihata, Kenichi

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 261, doi. 10.1002/cpdd.591
Publication type:: Article

Oral Bioavailability and Pharmacokinetics of Nonanimal Chondroitin Sulfate and Its Constituents in Healthy Male Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 336, doi. 10.1002/cpdd.587

By:

Volpi, Nicola;
Mantovani, Veronica;
Galeotti, Fabio;
Bianchi, Davide;
Straniero, Valentina;
Valoti, Ermanno;
Miraglia, Niccolò

Publication type:

Article

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Bapineuzumab: A Single‐Ascending‐Dose Study in Patients With Mild to Moderate Alzheimer Disease.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 326, doi. 10.1002/cpdd.584

By:

Lu, Ming;
Brashear, H. Robert

Publication type:

Article

Phase 1 Study of the Pharmacology of BTI320 Before High‐Glycemic Meals.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 395, doi. 10.1002/cpdd.583

By:

Luke, David R.;
Lee, Karen Ka Yan;
Rausch, Carl W.;
Cheng, Camille

Publication type:

Article

Comparative Randomized, Single‐Dose, Two‐Way Crossover Open‐Label Study to Determine the Bioequivalence of Two Formulations of Dalfampridine Tablets.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 355, doi. 10.1002/cpdd.574

By:

Al Bawab, Abdel Qader;
Alkhalidi, Bashar A.;
Albarahmieh, Esra'a;
Qassim, Sami M.A.;
Al‐Saifi, Mohammad A. D.

Publication type:

Article

Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 314, doi. 10.1002/cpdd.472

By:

Dawra, Vikas Kumar;
Cutler, David L.;
Zhou, Susan;
Krishna, Rajesh;
Shi, Haihong;
Liang, Yali;
Alvey, Christine;
Hickman, Anne;
Saur, Didier;
Terra, Steven G.;
Sahasrabudhe, Vaishali

Publication type:

Article

An Open‐Label, Phase 1 Study to Assess the Effects of Hepatic Impairment on Pomalidomide Pharmacokinetics.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 346, doi. 10.1002/cpdd.470

By:

Li, Yan;
Wang, Xiaomin;
Liu, Liangang;
Zhang, Chengyue;
Gomez, Diana;
Reyes, Josephine;
Palmisano, Maria;
Zhou, Simon

Publication type:

Article